MedPath

MOXIFLOXACIN HYDROCHLORIDE

These highlights do not include all the information needed to use MOXIFLOXACIN TABLETS safely and effectively. See full prescribing information for MOXIFLOXACIN TABLETS. MOXIFLOXACIN tablets, for oral use Initial U.S. Approval: 1999

Approved
Approval ID

6cd420c3-113e-4fc2-b59f-bfc7c485c14d

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 18, 2024

Manufacturers
FDA

Bryant Ranch Prepack

DUNS: 171714327

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

moxifloxacin hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code71335-2329
Application NumberANDA202632
Product Classification
M
Marketing Category
C73584
G
Generic Name
moxifloxacin hydrochloride
Product Specifications
Route of AdministrationORAL
Effective DateJune 25, 2020
FDA Product Classification

INGREDIENTS (9)

MOXIFLOXACIN HYDROCHLORIDEActive
Quantity: 400 mg in 1 1
Code: C53598599T
Classification: ACTIM
HYPROMELLOSE 2910 (6 MPA.S)Inactive
Code: 0WZ8WG20P6
Classification: IACT
FERRIC OXIDE REDInactive
Code: 1K09F3G675
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
POLYETHYLENE GLYCOL 4000Inactive
Code: 4R4HFI6D95
Classification: IACT
POVIDONE K30Inactive
Code: U725QWY32X
Classification: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

MOXIFLOXACIN HYDROCHLORIDE - FDA Drug Approval Details